101 related articles for article (PubMed ID: 8622856)
1. Activation of the erythropoietin gene in the majority of F-MuLV-induced erythroleukemias results in growth factor independence and enhanced tumorigenicity.
Howard JC; Berger L; Bani MR; Hawley RG; Ben-David Y
Oncogene; 1996 Apr; 12(7):1405-15. PubMed ID: 8622856
[TBL] [Abstract][Full Text] [Related]
2. Loss of p53 in F-MuLV induced-erythroleukemias accelerates the acquisition of mutational events that confers immortality and growth factor independence.
Wong KS; Li YJ; Howard J; Ben-David Y
Oncogene; 1999 Sep; 18(40):5525-34. PubMed ID: 10523829
[TBL] [Abstract][Full Text] [Related]
3. Temporal order and functional analysis of mutations within the Fli-1 and p53 genes during the erythroleukemias induced by F-MuLV.
Howard JC; Yousefi S; Cheong G; Bernstein A; Ben-David Y
Oncogene; 1993 Oct; 8(10):2721-9. PubMed ID: 8378083
[TBL] [Abstract][Full Text] [Related]
4. Bcl-2 expression in F-MuLV-induced erythroleukemias: a role for the anti-apoptotic action of Bcl-2 during tumor progression.
Howard JC; Li Q; Chu W; Zochodne B; Kapoor M; Ung Y; Rosen K; Ben-David Y
Oncogene; 2001 Apr; 20(18):2291-300. PubMed ID: 11402324
[TBL] [Abstract][Full Text] [Related]
5. p53-independent tumor growth and in vitro cell survival for F-MuLV-induced erythroleukemias.
Howard J; Ung Y; Adachi D; Ben-David Y
Cell Growth Differ; 1996 Dec; 7(12):1651-60. PubMed ID: 8959333
[TBL] [Abstract][Full Text] [Related]
6. Abnormal erythropoietin (Epo) gene expression in the murine erythroleukemia IW32 cells results from a rearrangement between the G-protein beta2 subunit gene and the Epo gene.
Chrétien S; Duprez V; Maouche L; Gisselbrecht S; Mayeux P; Lacombe C
Oncogene; 1997 Oct; 15(16):1995-9. PubMed ID: 9365246
[TBL] [Abstract][Full Text] [Related]
7. Insertional inactivation of the p53 gene during friend leukemia: a new strategy for identifying tumor suppressor genes.
Ben-David Y; Lavigueur A; Cheong GY; Bernstein A
New Biol; 1990 Nov; 2(11):1015-23. PubMed ID: 2101628
[TBL] [Abstract][Full Text] [Related]
8. Endogenous p53 regulation and function in early stage Friend virus-induced tumor progression differs from that following DNA damage.
Kelley LL; Hicks GG; Hsieh FF; Prasher JM; Green WF; Miller MD; Eide EJ; Ruley HE
Oncogene; 1998 Sep; 17(9):1119-30. PubMed ID: 9764822
[TBL] [Abstract][Full Text] [Related]
9. Inactivation of the p53 oncogene by internal deletion or retroviral integration in erythroleukemic cell lines induced by Friend leukemia virus.
Ben David Y; Prideaux VR; Chow V; Benchimol S; Bernstein A
Oncogene; 1988 Aug; 3(2):179-85. PubMed ID: 2842714
[TBL] [Abstract][Full Text] [Related]
10. FLI-1 inhibits differentiation and induces proliferation of primary erythroblasts.
Pereira R; Quang CT; Lesault I; Dolznig H; Beug H; Ghysdael J
Oncogene; 1999 Feb; 18(8):1597-608. PubMed ID: 10102630
[TBL] [Abstract][Full Text] [Related]
11. Loss of p53 tumor suppressor function is required for in vivo progression of Friend erythroleukemia.
Prasher JM; Elenitoba-Johnson KS; Kelley LL
Oncogene; 2001 May; 20(23):2946-55. PubMed ID: 11420707
[TBL] [Abstract][Full Text] [Related]
12. Production of erythropoietin by cloned malignant murine erythroid cells.
Choppin J; Casadevall N; Lacombe C; Wendling F; Goldwasser E; Berger R; Tambourin P; Varet B
Exp Hematol; 1985 Aug; 13(7):610-5. PubMed ID: 3861324
[TBL] [Abstract][Full Text] [Related]
13. Continuous Fli-1 expression plays an essential role in the proliferation and survival of F-MuLV-induced erythroleukemia and human erythroleukemia.
Cui JW; Vecchiarelli-Federico LM; Li YJ; Wang GJ; Ben-David Y
Leukemia; 2009 Jul; 23(7):1311-9. PubMed ID: 19282832
[TBL] [Abstract][Full Text] [Related]
14. Erythropoietin-induced erythroid differentiation of the human erythroleukemia cell line TF-1 correlates with impaired STAT5 activation.
Chrétien S; Varlet P; Verdier F; Gobert S; Cartron JP; Gisselbrecht S; Mayeux P; Lacombe C
EMBO J; 1996 Aug; 15(16):4174-81. PubMed ID: 8861946
[TBL] [Abstract][Full Text] [Related]
15. Employment of a [3H]thymidine-incorporation assay to distinguish the effects of different Friend erythroleukemia-inducing retroviruses on erythroid cell proliferation.
Ruscetti SK
J Natl Cancer Inst; 1986 Jul; 77(1):241-5. PubMed ID: 3459916
[TBL] [Abstract][Full Text] [Related]
16. Activation and inhibition of the erythropoietin receptor by a membrane-anchored erythropoietin.
Negre O; Fusil F; Henri A; Villette JM; Leboulch P; Beuzard Y; Payen E
Exp Hematol; 2008 Apr; 36(4):412-23. PubMed ID: 18295963
[TBL] [Abstract][Full Text] [Related]
17. Retroviral insertional activation of the Fli-3 locus in erythroleukemias encoding a cluster of microRNAs that convert Epo-induced differentiation to proliferation.
Cui JW; Li YJ; Sarkar A; Brown J; Tan YH; Premyslova M; Michaud C; Iscove N; Wang GJ; Ben-David Y
Blood; 2007 Oct; 110(7):2631-40. PubMed ID: 17586726
[TBL] [Abstract][Full Text] [Related]
18. Rearrangements of the Pim-1, c-myc, and p53 genes in Friend helper virus-induced mouse erythroleukemias.
Dreyfus F; Sola B; Fichelson S; Varlet P; Charon M; Tambourin P; Wendling F; Gisselbrecht S
Leukemia; 1990 Aug; 4(8):590-4. PubMed ID: 2143796
[TBL] [Abstract][Full Text] [Related]
19. p45(NFE2) is a negative regulator of erythroid proliferation which contributes to the progression of Friend virus-induced erythroleukemias.
Li YJ; Higgins RR; Pak BJ; Shivdasani RA; Ney PA; Archer M; Ben-David Y
Mol Cell Biol; 2001 Jan; 21(1):73-80. PubMed ID: 11113182
[TBL] [Abstract][Full Text] [Related]
20. p53 transgenic mice: accelerated erythroleukemia induction by Friend virus.
Lavigueur A; Bernstein A
Oncogene; 1991 Dec; 6(12):2197-201. PubMed ID: 1766668
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
